Abstract
The aim of this study was to determine the etiologic agents associated with community-acquired pneumonia in 104 French children ages 18 months to 13 years. Potential respiratory pathogens were identified in 87 (85%) cases; these included respiratory syncytial virus in ten, other viruses in 20,Streptococcus pneumoniae in 14, andMycoplasma pneumoniae (diagnosed by serologic procedures) in 43. Of 32 patients withMycoplasma pneumoniae infection who were initially treated with beta-lactam antibiotics, 30 failed treatment. Recovery from mycoplasma infection occurred rapidly in patients treated with macrolide antibiotics (which included spiramycin in 31 patients, josamycin in 7, and erythromycin in 3); however, cough persisted in 12 patients for one month. The high frequency ofMycoplasma pneumoniae infection in community-acquired pneumonia in children over 18 months of age must be considered when selecting an antibiotic for initial therapy.
Similar content being viewed by others
References
Isaacs D: Problems in determining the etiology of community-acquired childhood pneumonia. Pediatric Infectious Disease Journal 1989, 8: 143–148.
Claesson BA, Trollfors B, Brolin I, Granstrom M, Henrichsen J, Jodal U, Juto P, Kallings I, Kanklerski K, Lagergard T, Steinwall L, Strannegard O: Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatric Infectious Disease Journal 1989, 8: 856–861.
Ruuskanen O, Nohynek H, Ziegler T, Capeding R, Rikailainen H, Huovinen P, Leinenen M: Pneumonia in childhood; etiology and response to antimicrobial therapy. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 217–223.
Dagan R: Antibiotic treatment of pediatric community-acquired lower respiratory tract infections: challenges and possible solutions. Respiration 1993, 60, Supplement 1: 8–44.
Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC:Mycoplasma pneumoniae andChlamydia pneumoniae in padiatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. etythromycin ethylsuccinate. Pediatric Infectious Disease Journal 1995, 14: 471–477.
Nohynek H, Eskola J, Kleemola M, Jalonen E, Saikku P, Leinonen M: Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatric Infectious Disease Journal 1995, 14: 478–484.
Moulin F, Raymond J, Ravilly S, Iniguez JL, Lebon P, Gendrel D: Diagnostic value of serum interferon-alpha in lower respiratory tract infection of children. Pediatric Infectious Disease Journal 1996, 15: 883–886.
Grayston JT:Chlamydia pneumoniae (TWAR) infections in children. Pediatric Infectious Disease Journal 1994,13: 675–685.
Turner RB, Lande AE, Chase P, Hilton N, Weinberg D: Pneumonia in pediatric outpatients. Journal of Pediatrics 1987, 111: 194–200.
Bartlett JG, Mundy LM: Community-acquired pneumonia. New England Journal of Medicine 1995, 333: 1618–1624.
Friedland IR: Comparison of the response to the antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatric Infectious Disease Journal 1995, 14: 885–890.
Nohynek H, Valkeila E, Leinonen M, Eskola J: Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children. Pediatric Infectious Disease Journal 1995, 14: 484–490.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gendrel, D., Raymond, J., Moulin, F. et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur. J. Clin. Microbiol. Infect. Dis. 16, 388–391 (1997). https://doi.org/10.1007/BF01726370
Issue Date:
DOI: https://doi.org/10.1007/BF01726370